153 related articles for article (PubMed ID: 26521823)
1. Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.
Yoon IS; Son JH; Kim SB; Choi MK; Maeng HJ
Biol Pharm Bull; 2015; 38(11):1732-7. PubMed ID: 26521823
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells.
Maeng HJ; Chapy H; Zaman S; Pang KS
Eur J Pharm Sci; 2012 Jun; 46(3):149-66. PubMed ID: 22387228
[TBL] [Abstract][Full Text] [Related]
3. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
Ming X; Thakker DR
Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac.
Maeng HJ; Durk MR; Chow EC; Ghoneim R; Pang KS
Biopharm Drug Dispos; 2011 Mar; 32(2):112-25. PubMed ID: 21341280
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.
Zhou XJ; Fielman BA; Lloyd DM; Chao GC; Brown NA
Antimicrob Agents Chemother; 2006 Jul; 50(7):2309-15. PubMed ID: 16801406
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers.
Fok BS; Gardner S; Piscitelli S; Chen S; Chu TT; Chan JC; Tomlinson B
Clin Ther; 2013 Jan; 35(1):68-76. PubMed ID: 23274144
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers.
Lu C; Jia Y; Chen L; Ding Y; Yang J; Chen M; Song Y; Sun X; Wen A
J Clin Pharm Ther; 2013 Apr; 38(2):136-40. PubMed ID: 23278367
[TBL] [Abstract][Full Text] [Related]
9. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
10. Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.
Reddy KR; Matelich MC; Ugarkar BG; Gómez-Galeno JE; DaRe J; Ollis K; Sun Z; Craigo W; Colby TJ; Fujitaki JM; Boyer SH; van Poelje PD; Erion MD
J Med Chem; 2008 Feb; 51(3):666-76. PubMed ID: 18173234
[TBL] [Abstract][Full Text] [Related]
11. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
Kearney BP; Ramanathan S; Cheng AK; Ebrahimi R; Shah J
J Clin Pharmacol; 2005 Aug; 45(8):935-40. PubMed ID: 16027404
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D
Maeng HJ; Doan TNK; Yoon IS
Drug Dev Res; 2019 May; 80(3):333-342. PubMed ID: 30537097
[TBL] [Abstract][Full Text] [Related]
13. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers.
Huang J; Zhang Y; Huang X; Li L; Li Y; Wang K; Yang J; He Y; Lv Y; Zheng Q
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):8-14. PubMed ID: 24219967
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
16. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
17. Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.
Cullen JM; Li DH; Brown C; Eisenberg EJ; Cundy KC; Wolfe J; Toole J; Gibbs C
Antimicrob Agents Chemother; 2001 Oct; 45(10):2740-5. PubMed ID: 11557463
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
19. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
[TBL] [Abstract][Full Text] [Related]
20. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
